Differences in Cardiovascular and Renal Outcomes Between Sodium Glucose Co-Transporter-2 and Dipeptidyl Peptidase-4 Inhibitors Among Type 2 Diabetes Patients: A Real-World, Retrospective Cohort Study

Retrospective Cohort ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Renal Outcomes ◽

Comparison of cardiovascular and renal outcomes between sodium glucose co– transporter–2 and dipeptidyl peptidase–4 inhibitors among type 2 diabetes patients: a real–world, retrospective cohort study

Metabolism ◽

10.1016/j.metabol.2020.154606 ◽

2021 ◽

Vol 116 ◽

pp. 154606

Author(s):

Iskandar Idris ◽

Ruiqi Zhang ◽

Jil Billy Mamza ◽

Mike Ford ◽

Tamsin Morris ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Real World ◽

Retrospective Cohort ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Renal Outcomes ◽

Exposure to dipeptidyl‐peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta‐analysis

Diabetes Obesity and Metabolism ◽

10.1111/dom.14142 ◽

2020 ◽

Vol 22 (10) ◽

pp. 1925-1934

Author(s):

Mario Luca Morieri ◽

Benedetta Maria Bonora ◽

Enrico Longato ◽

Barbara Di Camilo ◽

Giovanni Sparacino ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Retrospective Cohort ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study

Acta Diabetologica ◽

10.1007/s00592-014-0663-2 ◽

2014 ◽

Vol 51 (6) ◽

pp. 1015-1023 ◽

Cited By ~ 29

Author(s):

Seoyoung C. Kim ◽

Robert J. Glynn ◽

Jun Liu ◽

Brendan M. Everett ◽

Allison B. Goldfine

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Cardiovascular Events ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Metformin combined with dipeptidyl peptidase-4 inhibitors or metformin combined with sulfonylureas in patients with type 2 diabetes: A real world analysis of the South Korean national cohort

Metabolism ◽

10.1016/j.metabol.2018.03.009 ◽

2018 ◽

Vol 85 ◽

pp. 14-22 ◽

Cited By ~ 1

Author(s):

Yeon Young Cho ◽

Sung-Il Cho

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Dipeptidyl Peptidase ◽

The South ◽

Dipeptidyl Peptidase 4 ◽

South Korean ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

National Cohort

Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany—A retrospective analysis of real-world data

Osteoporosis International ◽

10.1007/s00198-017-4051-y ◽

2017 ◽

Vol 28 (8) ◽

pp. 2421-2428 ◽

Cited By ~ 32

Author(s):

S. Dombrowski ◽

K. Kostev ◽

L. Jacob

Keyword(s):

Type 2 Diabetes ◽

Retrospective Analysis ◽

Real World ◽

Bone Fracture ◽

Dipeptidyl Peptidase ◽

Real World Data ◽

World Data ◽

Dipeptidyl Peptidase 4 ◽

Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study

Diabetes Therapy ◽

10.1007/s13300-018-0483-4 ◽

2018 ◽

Vol 9 (5) ◽

pp. 2133-2141 ◽

Cited By ~ 8

Author(s):

György Jermendy ◽

Zoltán Kiss ◽

György Rokszin ◽

Zsolt Abonyi-Tóth ◽

István Wittmann ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Antidiabetic Drugs ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Persistence To Treatment

Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2020.108546 ◽

2021 ◽

Vol 171 ◽

pp. 108546

Author(s):

Chen-Yi Wu ◽

Chun-Ying Wu ◽

Chung-Pin Li ◽

Yiing-Jenq Chou ◽

Yi-Hsian Lin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Bullous Pemphigoid ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

Endocrinology and Metabolism ◽

10.3803/enm.2019.34.1.80 ◽

2019 ◽

Vol 34 (1) ◽

pp. 80 ◽

Cited By ~ 8

Author(s):

Jae Hyun Bae ◽

Sunhee Kim ◽

Eun-Gee Park ◽

Sin Gon Kim ◽

Seokyung Hahn ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Renal Outcomes ◽

Cardioprotective effects of dipeptidyl peptidase-4 inhibitors versus sulfonylureas in addition to metformin: a nationwide cohort study of patients with type 2 diabetes

Diabetes & Metabolism ◽

10.1016/j.diabet.2021.101299 ◽

2021 ◽

pp. 101299

Author(s):

Jui Wang ◽

Hon-Yen Wu ◽

Kuo-Liong Chien

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Cardioprotective Effects

Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort Study

Diabetes Therapy ◽

10.1007/s13300-017-0297-9 ◽

2017 ◽

Vol 8 (5) ◽

pp. 1047-1055 ◽

Cited By ~ 3

Author(s):

Cheli Melzer Cohen ◽

Brian Larsen Thorsted ◽

Michael Lyng Wolden ◽

Gabriel Chodick ◽

Avraham Karasik

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Glycemic Control ◽

Real World ◽

Retrospective Cohort ◽

Insulin Degludec ◽

Real World Setting